Paris, Ile-de-France, FranceFounded 202230+ employeesPrivate
$32.2M raisedSeries A· last: series a (Apr 2026)· 3 rounds
Backed by(9 investors)
Unearthing, decoding, compounding what life wrote. Life has been writing for 3 billion years, 97% has never been read. Generare unhearts, decodes, compounds what life wrote. Our platform and team generate high-quality molecular data on unread chemistry, creating the dataset that will define a new paradigm for drug discovery.
